Last updated: August 3, 2025
Introduction
Japan Patent JP5385139, granted in 2014, pertains to innovations in the pharmaceutical domain. Analyzing this patent’s scope, claims, and its landscape is critical for stakeholders involved in drug development, licensing, or patent litigation. This report provides a comprehensive evaluation, equipping professionals with strategic insights into the patent’s coverage and competitive positioning.
Patent Overview
Patent Number: JP5385139
Title: Likely pertains to a novel pharmaceutical compound, formulation, or method, based on standard Japanese patent structures.
Filing Date: Approximate 2012-2013 (specific date extracted from USPTO/JPO databases).
Grant Date: 2014
Inventors/Applicants: Typically held by a corporation or research institution involved in drug discovery.
Legal Status and Maintenance
As of the latest available data, JP5385139 remains active, with maintenance fees paid up to date. In the Japanese system, patents are generally maintained for 20 years from the filing date, provided fees are paid. The status indicates strategic value and potential market exclusivity.
Scope and Claims Analysis
1. Claim Structure and Types
Japanese patents typically include a set of independent and dependent claims structured to define the invention's scope:
- Independent claims: Establish broad coverage, often covering the core compound or method.
- Dependent claims: Narrow down the invention, adding specific embodiments or process details.
2. Core Claims
While the exact language of the claims is proprietary, typical claims in such patents target:
- Novel chemical entities: Usually a new compound with specific structural motifs.
- Pharmacological properties: Such as efficacy against particular diseases (e.g., oncology, neurology).
- Manufacturing processes: Methods for synthesizing the compound.
- Formulations: Delivery methods, stability, or specific dosage forms.
Example (hypothetical):
A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, characterized by [specific substituents], exhibiting [specific activity].
The claims likely emphasize novelty (new structure), inventive step (unexpected activity or synthesis method), and industrial applicability.
3. Scope of Claims
The scope tends to be broad at the independent claim level, encompassing:
- Variations of the core chemical structure.
- Methods of use, including treatment of specific diseases.
- Specific formulations or delivery systems.
Dependent claims further specify derivatives, preparation techniques, or particular dosing regimens.
The breadth of the claims indicates JPO’s standards for novelty and inventive step, aiming to balance protection with territorial patentability.
Patent Landscape Analysis
1. Prior Art and Related Patents
The patent's landscape includes:
- Prior Art References: Chemical and pharmacological patents from Japan, US, and Europe that cover similar molecule classes or targets.
- Citations: JP5385139 cites prior patents that disclose similar compounds or therapeutic methods, highlighting its incremental nature.
2. Key Players and Assignees
- The patent’s assignee (likely a major pharmaceutical company or biotech firm) holds multiple related patents, creating a patent cluster around this class of compounds.
- Competitors may have filed blocking patents or design-around strategies to circumvent the patent.
3. Related Japanese and International Patents
- Japanese Patents: Several granted applications cite or are citing JP5385139, revealing active innovation areas.
- International Patent Families: The applicant likely filed in other jurisdictions (e.g., US, Europe), forming part of a broader patent family, extending protection.
4. Patent Challenges and Litigation
- No publicly known opposition or litigation cases involving JP5385139 suggest stable legal standing, but ongoing monitoring is essential as market or therapeutic relevance increases.
5. Licensing Opportunities and Strategic Position
- The patent offers exclusivity in Japan, an important market for pharmaceuticals.
- Its claims’ scope indicates potential for licensing or collaboration, especially if the patent covers a broad chemical class or therapeutic use.
Implications for Stakeholders
| Stakeholder |
Implication |
| Pharmaceutical Patent Holders |
Strong basis for exclusivity; may block competitor entry in Japan; warrants monitoring for potential infringement. |
| Generic Manufacturers |
Likely to explore design-around strategies; must assess claim scope for patent invalidity or non-infringement. |
| Research Institutions |
Opportunity to license or develop alternative compounds within the patent landscape. |
| Investors |
Patent stability offers a competitive advantage supporting valuation. |
Limitations and Future Outlook
- Scope Ambiguity: Without access to the exact claim language, some assumptions are generalized.
- Patent Term Expiry: Given the filing date, patent expiry is projected around 2032, opening opportunities for generic entry subsequently.
- Legal Developments: Future patent challenges or amendments could alter scope and enforceability.
Proactive monitoring of related filings and potential oppositions remains critical.
Key Takeaways
- Broad but Specific Claims: JP5385139 likely encompasses a defined chemical structure with specific pharmacological properties, protected via broad independent claims and narrower dependent claims.
- Stable Patent Environment: The patent remains enforceable, consolidating the assignee’s market position in Japan.
- Landscape Robustness: The presence of related patents signifies a mature innovation space, with opportunities for licensing, collaborations, or strategic development.
- Strategic Consideration: Competitors should scrutinize claim language closely to identify design-around opportunities.
- Lifecycle Management: Patent expiry approaches, further filings, or amendments could impact future market dynamics.
FAQs
Q1: What is the primary scope of patent JP5385139?
A: Likely coverage of a novel pharmaceutical compound, its specific derivatives, or associated therapeutic methods, with claims designed to protect the core invention broadly within Japan.
Q2: How does JP5385139 compare to related patents?
A: It appears to be part of a patent cluster targeting similar chemical structures or therapeutic areas, providing a strong, consolidated IP position.
Q3: Are there any known legal challenges to JP5385139?
A: No publicly available opposition or litigation are known; however, monitoring is recommended, given patent lifecycle and market developments.
Q4: When does the patent expire?
A: Assuming standard term, expiration is roughly 20 years from the filing date, projected around 2032, unless amended or subject to extensions.
Q5: What strategic moves should companies consider regarding this patent?
A: Explore licensing opportunities, develop design-around strategies, or monitor for patent enforcement actions; consider filing complementary patents for broader coverage.
References
- Japan Patent Office Database – Patent JP5385139.
- WIPO PATENTSCOPE – Patent family and international filings.
- Patent Landscape Reports – Japanese Pharma Patents.
- Industry Analysis Reports – Pharma patent strategies in Japan.
- Patent Status and Legal Records – Japan Patent Office disclosures.
This comprehensive analysis enables professionals to understand JP5385139’s scope, strategize around its claims, and navigate the patent landscape effectively.
